Results 21 to 30 of about 666,379 (164)

Hyperlipoproteinemia Type II

Nederlandsch tijdschrift voor geneeskunde, 2020
National Cancer Institute
openalex   +2 more sources

Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOOD [PDF]

Journal of Clinical Investigation, 1974
Peter O. Kwiterovich, Donald S. Fredrickson, Robert I. Levy   +2 more
openalex   +2 more sources

Familial Hyperlipoproteinemia Type II

, 1974
森下 玲子, 田代 正昭
openalex   +2 more sources

Eruptive Xanthomas Caused by Primary Type V Hyperlipoproteinemia

Internal medicine, 2021
A 39-year-old man (height, 170 cm; weight, 105 kg; body mass index, 36.3 kg/m) with dyslipidemia (no family history) and type II diabetes mellitus treated with 50 mg ipragliflozin, 1,500 mg metformin, and 0.2 mg pemafibrate was referred to our clinic. On
Yoshihiro Nakamura, Tsuyoshi Watanabe, N. Takizawa, Yoshiro Fujita   +3 more
semanticscholar   +1 more source

Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.

Journal of Lipid Research, 1982
Cholesteryl ester-rich beta-very low density lipoproteins (beta-VLDL) are beta-migrating lipoproteins that accumulate in the d < 1.006 g/ml fraction of plasma from cholesterol-fed animals and from patients with Type III hyperlipoproteinemia.
M Fainaru, R W Mahley, R L Hamilton, T L Innerarity   +3 more
doaj   +1 more source

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics [PDF]

Endocrinology and Metabolism, 2017
In recent studies, the reported prevalence of heterozygous familial hypercholesterolemia (FH) has been higher than in previous reports. Although cascade genetic screening is a good option for efficient identification of affected patients, diagnosis using
Sang-Hak Lee
doaj   +1 more source

Role of apolipoproteins E and C in type V hyperlipoproteinemia.

Journal of Lipid Research, 1988
Type V hyperlipoproteinemia is characterized by elevations of chylomicron (CM) and very low density lipoprotein (VLDL) triglycerides. The development of this lipid disorder involves a multitude of metabolic derangements including deficient clearance of ...
T Kuusi, M R Taskinen, T Solakivi, R Kauppinen-Mäkelin   +3 more
doaj   +1 more source

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis

Health Technology Assessment, 2023
Background Cascade testing the relatives of people with familial hypercholesterolaemia is an efficient approach to identifying familial hypercholesterolaemia.
Nadeem Qureshi, Bethan Woods, Rita Neves de Faria, Pedro Saramago Goncalves, Edward Cox, Jo Leonardi-Bee, Laura Condon, Stephen Weng, Ralph K Akyea, Barbara Iyen, Paul Roderick, Steve E Humphries, William Rowlands, Melanie Watson, Kate Haralambos, Ryan Kenny, Dev Datta, Zosia Miedzybrodzka, Christopher Byrne, Joe Kai   +19 more
doaj   +1 more source

Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes

Journal of Lipid Research, 1999
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and development of premature atherosclerosis. Although receptor binding-defective forms of apolipoprotein (apo) E are the common
Robert W. Mahley, Yadong Huang, Stanley C. Rall, Jr.   +2 more
doaj   +1 more source

Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones.

Journal of Lipid Research, 1979
In vivo studies have shown abnormalities in cholesterol and bile acid metabolism in primary hyperlipoproteinemia (HLP). The aim of the present investigation was to determine if the increased production of cholesterol in HLP type IV can be attributed to a
J Ahlberg, B Angelin, I Björkhem, K Einarsson, B Leijd   +4 more
doaj   +1 more source